InvestorsHub Logo
Followers 35
Posts 182
Boards Moderated 0
Alias Born 05/03/2020

Re: None

Sunday, 05/31/2020 5:39:56 PM

Sunday, May 31, 2020 5:39:56 PM

Post# of 403039
It's looking like Bril is your flagship drug with multiple clinical indications in areas such as immunotherapy, pandemic virus, bacterial-resistant infection, autoimmune disease, and etc.etc.

Bril is already a potential blockbuster drug in the making for CV19. And I'd peg their entire value as potentially at least $10 billion alone for any pharma to acquire IPIX. The CEO can throw in this Kevitrin for free and sell the company for $1.5B, or look to MERGE WITH ANOTHER COMPANY so it can expand its Bril's clinical pipeline. Jmo.

Great results should be done and out very soon. The question is, what are you going to do with that information? Now! And not after the facts.

The report below.... of contenders vs pretenders. Bril is our juggernaut character from X-men.

https://www.genengnews.com/category/covid-19-candidates/covid-19-antiviral/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News